New strategy to attack aggressive brain cancer shows promise
Time:2024-05-22 10:42:19 Source:politicsViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Previous:Andretti Global makes key engineering hire in bid to earn a spot in Formula 1
Next:Guardians ruin Francisco Lindor's Cleveland homecoming, trip Mets 3
You may also like
- Midwest storms: Large hail, torrential rain and tornadoes and more is coming
- Robust start of China's economy boosts global economic prospects
- Iris Law catches the eye in a semi
- Cambodia welcomes 1st Chinese flight, tourists to Siem Reap
- China sanctions former US lawmaker who supported Taiwan
- Camping picks up pace as holiday option
- BRICS summit expected to promote S. Africa's tourism sector
- Boeing's first astronaut launch is off until late next week to replace a bad rocket valve
- US Open champ Coco Gauff urges young Americans to vote